The Trump administration’s cuts to biomedical funding could have big repercussions for potential cures, including drugs that promise to ease Parkinson’s Disease. Several of the most promising drugs were developed with significant federal funding and under the auspices of the National Institutes of Health and the Parkinson’s Research Program — among dozens of research programs threatened by budget cuts.
Read the full story as it appeared in St. Louis Magazine by clicking here.
